1Pamphilon DH. Rransfusion policy//Apperley J, Carreras E, Gluekman E, et al. The EBMT handbook, Haematopoietic Stem Cell Transplantation. 5th ed Paris: European School of Haematology,2008 : 146-160.
2Dodds AJ. ABO incompatibility and blood product support//Atkinson K, Champlin R, Ritz J, et al. Clinical bone marrow and blood stem cell transplantation. 3rd ed,2004: 1077-1086.
3McCullough J. Principles of transfusion support before and after hematopoietic cell transplantation//Blume KG, Forman SJ, Appelbaum FR, et al. Thomas' hematopoietic cell transplantation. 3rd ed, 2004: 833-846.
4Transfusion biology and therapy ,//Harser FBK and Loscalzo LJ, Harrison's principles of internal medicine. 17th ed. New Nork: McGraw-Hill Companies, 2008.
5Klein HG, Dzik WH, Strauss RG, et al. Leukocyte-reduced blood component therapy//Hematology-1992. The education program of The American Society of Hematology: 76-85.
6Leitman SF, Holland PV. Irradiation of blood products: indications and guidelines. Transfusion, 1985, 25(4): 293-303.
2Gluckman E, Rocha V. Cord blood transplantation.. state of the art [J]. Haematologica, 2009,94 (4) : 4451- 4454.
3Romee R, Weisdorf DJ, Brunstein C,et al. Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation [J]. Bone Marrow Transplant. 2013,48(8) 1046-1049.
4Raimondi R, Soli M, Lamparelli T, Bacigalupo A, et al. ABO-incompatible bone marrow transplantation: a GIT- MO survey of current practice in Italy and comparison with the literature[J]. Bone Marrow Transplant,2004,34(4): 321-329.
5Remberger M, Watz E, Ringdrn O, et al. Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant,2007,13(6):675-682.
6Benjamin RJ, Antin JH. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity[J]. Transfusion, 1999,39(11- 12): 1273 - 1274.
7Worel N, Kalhs P, Keil F, et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation [J]. Transfusion,2003,43(8): 1153-1161.
8Stussi G, Muntwyler J, Passweg JR, et al.Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation[J]. Bone Marrow Transplant,2002,30(2): 87-93.
9Resnick IB, Tsirigotis PD, Shapira MY, et al. ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients[J]. Biol Blood Marrow Transplant,2008,14(4):409-417.
10Sieff C, Bicknell D, Caine G, et al. Changes in cell surface antigen expression during hemopoietic differentiation [J]. Blood, 1982,60(3):703-713.t.
